Inflammatory myopathies and human leukocyte antigen

Yuko Ohnuki, Shigeaki Suzuki, Takashi Shiina

Research output: Contribution to journalArticle

Abstract

Idiopathic inflammatory myopathies (IIM) are a heterogeneous group of subacute, chronic or acute systemic immune-mediated diseases of the skeletal muscles. Recently, research has shown the utility of adding new classifications of myopathies, mainly based on their pathology and the presence of specific autoantibodies. In addition, developments in genetics have helped reveal the genetic background of IIM. The human leukocyte antigen genomic region has been consistently shown to be the strongest genetic risk factor for IIM. The present review summarizes the previous and current literature on human leukocyte antigen analysis of IIM, as well as future directions for research.

Original languageEnglish
JournalClinical and Experimental Neuroimmunology
DOIs
Publication statusAccepted/In press - 2017

Fingerprint

Myositis
HLA Antigens
Immune System Diseases
Muscular Diseases
Research
Autoantibodies
Skeletal Muscle
Pathology

Keywords

  • Human leukocyte antigen
  • Idiopathic inflammatory myopathy
  • Myositis-specific autoantibodies

ASJC Scopus subject areas

  • Neuroscience (miscellaneous)
  • Immunology
  • Immunology and Microbiology (miscellaneous)
  • Clinical Neurology

Cite this

Inflammatory myopathies and human leukocyte antigen. / Ohnuki, Yuko; Suzuki, Shigeaki; Shiina, Takashi.

In: Clinical and Experimental Neuroimmunology, 2017.

Research output: Contribution to journalArticle

@article{a656d72d2c00461f987be86fb321656f,
title = "Inflammatory myopathies and human leukocyte antigen",
abstract = "Idiopathic inflammatory myopathies (IIM) are a heterogeneous group of subacute, chronic or acute systemic immune-mediated diseases of the skeletal muscles. Recently, research has shown the utility of adding new classifications of myopathies, mainly based on their pathology and the presence of specific autoantibodies. In addition, developments in genetics have helped reveal the genetic background of IIM. The human leukocyte antigen genomic region has been consistently shown to be the strongest genetic risk factor for IIM. The present review summarizes the previous and current literature on human leukocyte antigen analysis of IIM, as well as future directions for research.",
keywords = "Human leukocyte antigen, Idiopathic inflammatory myopathy, Myositis-specific autoantibodies",
author = "Yuko Ohnuki and Shigeaki Suzuki and Takashi Shiina",
year = "2017",
doi = "10.1111/cen3.12422",
language = "English",
journal = "Clinical and Experimental Neuroimmunology",
issn = "1759-1961",
publisher = "John Wiley and Sons Ltd",

}

TY - JOUR

T1 - Inflammatory myopathies and human leukocyte antigen

AU - Ohnuki, Yuko

AU - Suzuki, Shigeaki

AU - Shiina, Takashi

PY - 2017

Y1 - 2017

N2 - Idiopathic inflammatory myopathies (IIM) are a heterogeneous group of subacute, chronic or acute systemic immune-mediated diseases of the skeletal muscles. Recently, research has shown the utility of adding new classifications of myopathies, mainly based on their pathology and the presence of specific autoantibodies. In addition, developments in genetics have helped reveal the genetic background of IIM. The human leukocyte antigen genomic region has been consistently shown to be the strongest genetic risk factor for IIM. The present review summarizes the previous and current literature on human leukocyte antigen analysis of IIM, as well as future directions for research.

AB - Idiopathic inflammatory myopathies (IIM) are a heterogeneous group of subacute, chronic or acute systemic immune-mediated diseases of the skeletal muscles. Recently, research has shown the utility of adding new classifications of myopathies, mainly based on their pathology and the presence of specific autoantibodies. In addition, developments in genetics have helped reveal the genetic background of IIM. The human leukocyte antigen genomic region has been consistently shown to be the strongest genetic risk factor for IIM. The present review summarizes the previous and current literature on human leukocyte antigen analysis of IIM, as well as future directions for research.

KW - Human leukocyte antigen

KW - Idiopathic inflammatory myopathy

KW - Myositis-specific autoantibodies

UR - http://www.scopus.com/inward/record.url?scp=85031508790&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85031508790&partnerID=8YFLogxK

U2 - 10.1111/cen3.12422

DO - 10.1111/cen3.12422

M3 - Article

AN - SCOPUS:85031508790

JO - Clinical and Experimental Neuroimmunology

JF - Clinical and Experimental Neuroimmunology

SN - 1759-1961

ER -